Nivolumab-Induced Concomitant Severe Upper and Lower Gastrointestinal Immune-Related Adverse Effects

Immunotherapy agents such as cytotoxic T-lymphocyte antigen-4 and programed cell death protein-1 inhibitors show efficacy in cancer therapy but are associated with immune-related adverse events. It commonly presents as diarrhea but can cause colitis, mimicking inflammatory bowel disease. Our patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhatem, Albert, Patel, Krishan, Eriksen, Brenda, Bukhari, Sarosh, Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145206/
https://www.ncbi.nlm.nih.gov/pubmed/32309466
http://dx.doi.org/10.14309/crj.0000000000000249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145206/
https://www.ncbi.nlm.nih.gov/pubmed/32309466
http://dx.doi.org/10.14309/crj.0000000000000249

Ejemplares similares